MetrioPharm ^Company

MetrioPharm AG is a pharmaceutical development company that focuses on developing drugs for chronic inflammatory diseases such as psoriasis, arthritis, and multiple sclerosis. Their goal is to make the therapy of chronic inflammatory diseases more effective and tolerable, and to significantly prolong the healthy lifespan of millions of people. They were founded in 2007 and are headquartered in Zurich with research facilities in Berlin. MetrioPharm is a clinical-stage company that develops safer and more effective treatments based on first-in-class self-regulating immunomodulators for inflammatory and infectious diseases.